Industry News
Zebrafish Provide Insight Into Melanoma
Jun 19, 2012
A transparent member of the minnow family is providing researchers at Weill Cornell Medical College in New York City with insight into human melanoma - a form of skin cancer - that may lead to new or repurposed drug treatments, for skin and other cancers... Read More
BI-1 Suppression Reduced Human Lung Cancer Tumor Growth In Animal Models
Jun 19, 2012
A multi-institutional research study has uncovered a new mechanism that may lead to unique treatments for lung cancer, one of the leading causes of death worldwide... Read More
New Sequencing Method Finds Gaps That Can Lead To Disease
Jun 19, 2012
Scientists worldwide are racing to sequence DNA - decipher genetic blueprints - faster and cheaper than ever by passing strands of the genetic material through molecule-sized pores. Now, University of Utah scientists have adapted this "nanopore" method to find DNA damage that can lead to mutations and disease... Read More
NICE Denies Patient Access To Breakthrough Skin Cancer Pill
Jun 19, 2012
Negative draft decision for Zelboraf (vemurafenib) highlights challenges facing future value-based pricing implementation and UK access to medicines.Roche is extremely disappointed with the preliminary decision that NICE is not planning to recommend Zelboraf (vemurafenib) to be available on the NHS for the treatment of BRAF mutation positive unresectable or metastatic melanoma... Read More
Engineered Nanoparticles Promise To Improve Blood Cancer Treatment
Jun 19, 2012
Researchers from the University of Notre Dame have engineered nanoparticles that show great promise for the treatment of multiple myeloma (MM), an incurable cancer of the plasma cells in bone marrow... Read More
Patient Outcomes In Lung Cancer Resections Influenced By Hospital Volume And Surgeon Specialty
Jun 19, 2012
In other studies, outcomes of specific surgeries has been shown to improve when performed at high-volume centralized centers. Researchers from the Netherlands Cancer Institute wanted to understand if patients undergoing lung cancer resections would benefit from having their procedures performed in a high-volume specialized center... Read More
Improved Understanding Of Childhood Brain Tumors Should Lead To New Treatments
Jun 19, 2012
Researchers at The University of Nottingham have identified three sets of genetic markers that could potentially pave the way for new diagnostic tools for a deadly type of brain tumour that mainly targets children... Read More
Network Approach To Drug Design May Yield More Effective And Less Toxic Cancer Drugs
Jun 19, 2012
A new approach to drug design, pioneered by a group of researchers at the University of California, San Francisco (UCSF) and Mt. Sinai, New York, promises to help identify future drugs to fight cancer and other diseases that will be more effective and have fewer side effects... Read More
MESUPRON® Met Its Primary Objective Of Demonstrating Efficacy In The Proof Of Concept Phase II Breast Cancer Trial
Jun 19, 2012
WILEX AG (ISIN DE0006614720 / WL6 / Frankfurt Stock Exchange) published data last week from its Phase II trial with its oral drug candidate MESUPRON® in first line treatment of patients with HER2-receptor negative metastatic breast cancer... Read More
MESUPRON® Met Its Primary Objective Of Demonstrating Efficacy In The Proof Of Concept Phase II Breast Cancer Trial
Jun 19, 2012
WILEX AG (ISIN DE0006614720 / WL6 / Frankfurt Stock Exchange) published data last week from its Phase II trial with its oral drug candidate MESUPRON® in first line treatment of patients with HER2-receptor negative metastatic breast cancer... Read More
Previous Page Next Page